Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer

NCT00047710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Bevacizumab
DRUG: Capecitabine
RADIATION: Radiotherapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]